Please assess the completion status of the following clinical trial:

Trial Title: Treatment for Nicotine Addiction in Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Must be 18yrs to 45yr old woman, read and write in English.~* Must smoke at least 5 or more cigarettes a day~* FTND score at least 4 or higher~* A CO reading of 10 or higher during screening~* Must be in good health as verified by medical history, screening exam, screen laboratory tests.~Exclusion Criteria:~* Excluded if using psychotropic medications, have contraindications to tolcapone use (e.g.. liver problems, allergy to tolcapone, history of no traumatic rhabdomyolysis or hyperpyrexia, confusion possibly related to medication), have other substance use disorder, are pregnant or breast feeding, have a current psychotic disorder, bipolar disorder, homicidal or suicidal ideation, have current (past month) substance use disorder, other than nicotine dependence, or are unable to fulfill the scheduled visits and procedures.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Tolcapone (Type: ACTIVE_COMPARATOR): 100mg tolcapone three times a day for 7 days then 100mg once a day on day 8
- Sugar Pill (Type: PLACEBO_COMPARATOR): Sugar pill

Based on this trial design, predict the completion outcome and termination type (if applicable).